*By Carlo Versano*
As Canadians celebrated Wednesday's cannabis legalization, one California-based dispensary completed the largest acquisition in the industry to date in America, becoming the most valuable U.S. pot company in the process.
MedMen's purchase of medical marijuana vendor PharmaCann for $682 million in stock marks a turning point in the push toward federal legalization, said the company's SVP of corporate communication, Daniel Yi.
Speaking to Cheddar from the floor of MedMen's original retail outpost in West Hollywood, Calif., on an "historic day" for cannabis users, Yi said the deal would not have been possible when the company opened its first store in 2015.
Changing consumers' attitudes toward the drug ー reflected first by investors and then some politicians ー has allowed MedMen to scale its operation, which now includes 14 retail locations in four states. Yi said the plan is to expand to 66 locations in two years.
Yi also said he hopes the legalization efforts in Canada will exert pressure on the "crazy federal laws" for marijuana in the U.S., where it's still classified as a Schedule I narcotic by the DEA ー a category that also includes heroin and cocaine.
Canada's entire legal weed market is estimated to be worth around $6.5 billion ー far less than the established $11 billion market in just the state of California. The potential national cannabis market in the U.S. is $75 billion, Yi said.
"From an economic standpoint, I don't think Canada is going to be a huge game changer."
But what it does politically will be priceless, he said, by "expanding a global conversation" over the potential for cannabis ー whether it's as an opioid replacement or just as a cure for a stressful week.
For full interview [click here](https://cheddar.com/videos/medmen-watches-canadas-cannabis-legalization-roll-out).
Not only is April Financial Literacy Month, it’s also the kickoff of the spring homebuying season. So now is the time to make sure you have a financial plan in place – and why it might not be wise for that to include buying your first home.
While the U.S. may slowly be on the path to lowering inflation (and therefore interest rates), Europe has thoroughly trounced America, putting it on the path to lower rates by this summer.
April's release of the monthly Housing Starts and Building Permits reports by the Census Bureau provides crucial insights into the construction activity in the housing market. These reports are an economic indicator, shedding light on the current state of the housing market and its broader economic impact.
Caitlin Clark is heading to the Indiana Fever, the number one draft pick and the highest-scoring college basketball player of all time. And while she may not be getting millions from the WNBA, there's a few ways she'll net compensation for her generational talents.
Author of 'Clean Meat,' Paul Shapiro joins Cheddar to discuss how the cellular agricultural revolution helps lower rates of foodborne illness and greatly improves environmental sustainability. Plus, how his company The Better Meat Co. is bringing healthier food options to the table.
Recent headlines might make it sound like World War III is imminent, but when it comes to your finances, it's not the time to panic. The market is coming off its longest winning streak since 2011.
You may have noticed fewer new venture capital-backed startups (like Airbnb or Uber) lately. The market slowed to a crawl after 2021, but things are expected to take off again in 2025.
Corporate earnings season is underway, that time when companies share their billions in sales or double-digit profits. But the data shows even companies are struggling with high inflation and interest rates.
Boeing continues their terrifying trend of having their planes fall apart mid-flight, inflation — checks notes — is still up and the future of AI looks terrifying. Cheery!
Food waste – uneaten scraps or leftovers sent to landfills – is responsible for 10% of global emissions. Mill, a new product from the co-founder of Nest, thinks technology can play a role in eliminating it.
